• Maternal Exposure to Environmental Pollution Increases Asthma Risk in Offspring for 3 Generations, Study Finds
  • Samumed Completes Phase 1 Study of Potential IPF Treatment with Positive Results
  • Sunovion Divests US Market Rights on Asthma and Allergic Rhinitis Therapies to Focus on COPD
  • Mount Sinai, Theragene Collaborate to Develop New Gene Therapy for Pulmonary Hypertension
  • Esbriet, Ofev Remain the Most Reliable Therapies for Idiopathic Pulmonary Fibrosis, Comparison Study Shows
  • Researchers Identify a Type of Immune Cells that Contribute to Lung Fibrosis
  • High Sugar Intake While Pregnant May Increase Child’s Risk of Developing Allergic Asthma, Study Finds
  • Trial Underway in Rare Lung Disease That Can Cause PF and Targets People from Puerto Rico
  • Vectura Signs Agreement with Sandoz to Develop Generic Combination Therapy for Asthma and COPD in the U.S.
  • Study Supports the Development of Envisia Genomic Classifier for IPF Diagnosis
  • Respiratory Hospitalization Rates May Improve Outcome Assessments in IPF Trials, Researchers Suggest
  • New Esbriet Tablets for IPF Treatment Now Available in Europe

Pulmonary Fibrosis

Asthma

Bronchiectasis

BRONCHIOLITIS

CHRONIC BRONCHITIS

COPD

 CYSTIC FIBROSIS

EMPHYSEMA

IDIOPATHIC PULMONARY FIBROSIS

LUNG CANCER

PNEUMONIA

PULMONARY HYPERTENSION

SCLERODERMA